Literature DB >> 12478816

Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial.

Claudio Fresco1, Aldo P Maggioni, Stefano Signorini, Piera A Merlini, Paolo Mocarelli, Gianna Fabbri, Donata Lucci, Marco Tubaro, Marinella Gattone, Carlo Schweiger.   

Abstract

BACKGROUND: The aim of this study was to prospectively evaluate the magnitude of the variations in lipid levels in a large population of patients admitted for acute myocardial infarction (MI) and unstable angina (UA). Clinical data and blood samples were prospectively collected from consecutive patients with MI and UA.
METHODS: The study population consisted of patients with symptoms lasting < or = 12 hours (for MI) or with the last episode of rest pain within 12 hours and associated with ECG changes (for UA). The exclusion criteria were recent hospitalization for any reason or current treatment with lipid-lowering drugs. Blood samples were obtained at admission, the following morning, at discharge and after 3 months. Samples were centrifuged immediately and 4 aliquots of serum were stored at -20 degrees C. The measurements were performed centrally.
RESULTS: We enrolled 1864 patients (1275 with MI and 589 with UA). Serum levels of total and LDL-cholesterol decreased significantly after admission, both in MI and UA patients. After 3 months, serum levels of total cholesterol returned to baseline, while those of LDL-cholesterol were still significantly lower. Between admission and the following morning, total and LDL-cholesterol decreased significantly by 7 and 10% respectively for MI and by 5 and 6% for UA. Lipid measurements not performed at admission accounted for a significant decrease in the number of patients identifiable as hyperlipidemic and suitable for lipid-lowering treatment (18% of MI patients and 11% of UA patients).
CONCLUSIONS: Serum cholesterol concentrations drop significantly during hospitalization for an acute coronary syndrome after a few hours from admission to the coronary care unit. Lipid profile assessment should be scheduled at admission in order to correctly identify hyperlipidemic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478816

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  8 in total

Review 1.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

2.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

3.  Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome.

Authors:  Dagmar Vondrakova; Petr Ostadal; Andreas Kruger
Journal:  Lipids Health Dis       Date:  2010-07-14       Impact factor: 3.876

Review 4.  The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes.

Authors:  Abhinav Goyal; John L Petersen; Kenneth W Mahaffey
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

5.  Prevalence of Conventional Risk Factors and Evaluation of Baseline Indices Among Young and Elderly Patients with Coronary Artery Disease.

Authors:  Arsalan Majeed Adam; Aiman Rehan; Nageen Waseem; Unzela Iqbal; Hira Saleem; Muhammad Armughan Ali; Ali Tariq Shaikh; Ansab Godil
Journal:  J Clin Diagn Res       Date:  2017-07-01

6.  Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease.

Authors:  Héctor González-Pacheco; Jesús Vargas-Barrón; Maite Vallejo; Yigal Piña-Reyna; Alfredo Altamirano-Castillo; Pedro Sánchez-Tapia; Carlos Martínez-Sánchez
Journal:  Ther Clin Risk Manag       Date:  2014-10-06       Impact factor: 2.423

7.  ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes.

Authors:  Furio Colivicchi; Michele Massimo Gulizia; Marcello Arca; Maurizio Giuseppe Abrignani; Gian Piero Perna; Gian Francesco Mureddu; Federico Nardi; Carmine Riccio
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

8.  Serial measurement of lipid profile and inflammatory markers in patients with acute myocardial infarction.

Authors:  Amit Kumar Shrivastava; Harsh Vardhan Singh; Arun Raizada; Sanjeev Kumar Singh
Journal:  EXCLI J       Date:  2015-04-10       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.